Register Login

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Abstract

Introduction
COVID-19 is a fast-spreading and alarming global public health issue1. Evans’ syndrome, in contrast, is a rare condition which is characterised by autoimmune disorders, such as autoimmune haemolytic anaemia (AIHA) and immune thrombocytopenia and/or immune neutropenia, which occur simultaneously or consecutively2.
The recommended first-line treatment for Evans’ syndrome is corticosteroids, but these are potentially harmful in patients with COVID-19. On the other hand, intravenous immunoglobulins and other non-immunosuppressive treatments are not adequately successful treatment options in AIHA. In this article, we describe how we treated a case of COVID-19 in a patient who presented with Evans Syndrome.

References

Downloads

PDF
Authors

Nazlim Aktug Demir Department of Infectious Diseases and Clinical Microbiology

Abdulkadir Basturk Department of Haematology

Onur Ural Department of Infectious Diseases and Clinical Microbiology

Sua Sumer Department of Infectious Diseases and Clinical Microbiology

Batuhan Erdogdu Department of Haematology

Hatice E. Kiratli Department of Infectious Diseases and Clinical Microbiology

Jale B. Celik Department of Anaesthesiology

Mustafa Koplay Department of Radiology

Husamettin Vatansev Department of Biochemistry, Selcuk University, Faculty of Medicine, Konya, Turkey

  • Abstract viewed - 719 times
  • PDF downloaded - 124 times